April 7, 2021Qelbree, a new nonstimulant medication for ADHD, has received FDA approval for treatment of attention deficit hyperactivity disorder in patients 6 to 17 years of age. Qelbree is the first nonstimulant ADHD medication to receive FDA approval for use in children in more than a decade.
Intuniv was the last branded, non-scheduled ADHD medication to be approved by the FDA in 2009. Supernus plans to launch Qelbree in the U.S.
in the second quarter, during back-to-school season for many families.Formerly known as SPN-812, Qelbree is a serotonin norepinephrine modulating agent. Its active ingredient, viloxazine hydrochloride, was previously marketed as an antidepressant in Europe.
Mental.guide is your guide in the world of psychology. In our online-journal you will find answers to many questions: how to overcome stress and depression, how to control your worry, how to manage anxiety and phobia, how to start loving and respecting yourself and many others.
Here you will get pieces of advice from the psychologists who will help you understand yourself better and start living in a harmony with this world around. Everyday updates are waiting for you here. So, if your feel upset, depressed and worried our psycho guide is ready to help you! We are your online help that is always at hand.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6